Abbisko Therapeutics Co, Ltd
Clinical trials sponsored by Abbisko Therapeutics Co, Ltd, explained in plain language.
-
New daily pill aims to boost growth in kids with dwarfism
Disease control Not yet recruitingThis study is testing a new daily oral drug called ABSK061 in children with achondroplasia, the most common form of dwarfism. The main goals are to see if the drug is safe and if it can help children grow taller and improve their body proportions. The study will involve up to 110…
Phase: PHASE1, PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo targets tough lung cancer mutation
Disease control Not yet recruitingThis study is testing the safety and effectiveness of a new two-drug combination (ABSK043 plus glecirasib) for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. It will enroll up to 86 adults who have either been previously treat…
Phase: PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC